Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYFS1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,528
Award facts
- Contract value 100% obligated
- $29,528.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a firm fixed price ceiling value of $29,528.47 and an ultimate completion date of September 11, 2025. This delivery order is unclassified as a set-aside contract and represents a competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards covering a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. All reviewed contract awards demonstrate the company's capability to compete successfully in open procurement processes, with delivery orders typically structured as firm fixed price transactions ranging from nominal amounts to substantial orders. The DLA Pharmaceutical Prime Vendor Global Program is planning to establish Generation V contracts with multiple regional awards, potentially involving three or more contractors to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FYFS1?
SPE2DB25FYFS1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FYFS1 worth?
The government has obligated $29,528 on SPE2DB25FYFS1.
Is contract SPE2DB25FYFS1 an order under another contract?
Yes. SPE2DB25FYFS1 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYFS1 competed?
The extent of competition for SPE2DB25FYFS1 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award